Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Abatacept for Patients With Inflammatory Arthritis Associated With Sjögren's Syndrome: an Open-Label Phase II Study

NCT02027298 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.

NCT NCT02027298
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02027298 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Abatacept for Patients With Inflammatory Arthritis Associated With Sjögren's Syndrome: an Open-Label Phase II Study
Lead sponsor
The Cleveland Clinic
Phase
Phase 2
Overall status
Withdrawn
Start date
November 30, 2013
Completion date
October 31, 2014
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

inflammatory arthritis, primary sjogren's syndrome, rheumatoid arthritis, secondary sjogren's syndrome